Hepatitis Monthly

Published by: Neoscriber Demo Publisher

Relationship between Antibodies to Hepatitis C Virus and Human Immunodeficiency Virus among Thai Selected Groups

Pipat Luksamijarulkul 1 , * and Somporn kantharadussadee Triamchaisri 2
Authors Information
1 Department of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand
2 Department of Public Health Nursing, Faculty of Public Health, Mahidol University, Bangkok, Thailand
Article information
  • Hepatitis Monthly: March 31, 2009, 9 (1); e92953
  • Published Online: March 31, 2009
  • Article Type: Brief Report
  • Received: May 05, 2019
  • Accepted: March 31, 2009

To Cite: Luksamijarulkul P, Triamchaisri S K. Relationship between Antibodies to Hepatitis C Virus and Human Immunodeficiency Virus among Thai Selected Groups, Hepat Mon. 2009 ; 9(1):e92953.

© 2009, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Cohen J. The scientific challenge of hepatitis C. Science. 1999;285(5424):26-30.
  • 2. Nur YA, Groen J, Elmi AM, Ott A, Osterhaus AD. Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia. Epidemiol Infect. 2000;124(1):137-41.
  • 3. Holland CA, Ma Y, Moscicki B, Durako SJ, Levin L, Wilson CM. Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study. Adolescent Medicine HIV/AIDS Research Network. Sex Transm Dis. 2000;27(5):296-303.
  • 4. Luksamijarulkul P, Drph ST, Triamchaisri S. Risk behaviors and life skills towards sexually transmitted and blood-borne infections among Thai married couples. J Med Assoc Thai. 2007;90(5):962-70.
  • 5. Dolan MJ, Clerici M, Blatt SP, et al. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis. 1995;172(1):79-87.
  • 6. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15(1):7-16.
  • 7. Zoulim F, Chevallier M, Maynard M, Trepo C. Clinical consequences of hepatitis C virus infection. Rev Med Virol. 2003;13(1):57-68.
  • 8. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet. 1999;353(9160):1253-7.
  • 9. Stary A, Kopp W, Hofmann H, Heller-Vitouch C, Kunz C. Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. Sex Transm Dis. 1992;19(5):252-8.
  • 10. Russi JC, Serra M, Vinoles J, et al. Sexual transmission of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 infections among male transvestite comercial sex workers in Montevideo, Uruguay. Am J Trop Med Hyg. 2003;68(6):716-20.
  • 11. Papaevangelou V, Pollack H, Rochford G, et al. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women. J Infect Dis. 1998;178(4):1047-52.
  • 12. Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr. 2001;26(5):466-72.
  • 13. Fuster D, Planas R, Muga R, et al. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy. AIDS Res Hum Retroviruses. 2004;20(12):1293-7.
  • 14. Schiavini M, Angeli E, Mainini A, et al. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002. HIV Med. 2006;7(5):331-7.
  • 15. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44(1 Suppl):S6-9.
  • 16. Sawanpanyalert P, Boonmar S, Maeda T, Matsuura Y, Miyamura T. Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand. J Epidemiol Community Health. 1996;50(2):174-7.
  • 17. Songsivilai S, Jinathongthai S, Wongsena W, Tiangpitayakorn C, Dharakul T. High prevalence of hepatitis C infection among blood donors in northeastern Thailand. Am J Trop Med Hyg. 1997;57(1):66-9.
  • 18. Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health. 2004;35(1):147-54.
  • 19. Taketa K, Ikeda S, Suganuma N, et al. Differential seroprevalences of hepatitis C virus, hepatitis B virus and human immunodeficiency virus among intravenous drug users, commercial sex workers and patients with sexually transmitted diseases in Chiang Mai, Thailand. Hepatol Res. 2003;27(1):6-12.
  • 20. Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW. Hepatitis C virus reinfection in injection drug users. Hepatology. 2006;44(5):1139-45.
  • 21. Tanikawa K. Relationship between Hepatitis C and Alcoholic Liver Disease. Asian Medical Journal. 1994;37:165-70.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments